# EDGAR Filing Document

**Accession Number:** 0001064642
**File Stem:** 0001410368-26-020144
**Filing Date:** 2026-2
**Character Count:** 24635
**Document Hash:** a9ae6f591569e077111072556bf6b398
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-020144.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0001410368-26-020144

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**PERIOD START**: 20260630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SPDR SERIES TRUST
- **CENTRAL INDEX KEY:** 0001064642

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08839
- **FILM NUMBER:** 26690041

**BUSINESS ADDRESS:**
- **STREET 1:** ONE CONGRESS STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02114
- **BUSINESS PHONE:** 6176643920

**MAIL ADDRESS:**
- **STREET 1:** ONE CONGRESS STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02114

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STREETTRACKS SERIES TRUST
- **DATE OF NAME CHANGE:** 20000925

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INDEX EXCHANGE LISTED SECURITIES TRUST
- **DATE OF NAME CHANGE:** 19980622

## Series and Classes Contracts Data

### State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF (Series ID: S000012321)

| Class ID   | Class Name                                         | Ticker Symbol   |
|:---|:---|:---|
| C000033537 | State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | XPH             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** SPDR SERIES TRUST

- **b. Investment Company Act file number:** 811-08839

- **c. CIK number of Registrant:** 0001064642

- **d. LEI of Registrant:** 5493004JVD6CQEEJSS37

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** One Congress Street

  - **City:** Boston

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02114

  - **Telephone number:** 617-664-8594

**Item A.2. Information about the Series.**

- **a. Name of Series:** State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000012321

- **c. LEI of Series:** 549300YVZ2R8N1KQH698

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-06-30

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $245362791.23

**Total Liabilities:** $15386369.12

**Net Assets:** $229976422.11

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000033537 | 3.61%                | 10.07%               | 2.68%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $4495209.13              | $1828073.63                                |
| Month 2  | $2591277.18              | $15985793.04                               |
| Month 3  | $16762524.88             | $-9766841.32                               |

### Schedule of Portfolio Investments

| Name                             | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ANI Pharmaceuticals Inc          | ANI Pharmaceuticals Inc                                    | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     52229 | NS      | $4122957.26   | 1.79%             |  |  |  | No            |                  1 | On Loan: —       |
| State Street Global Advisors     | State Street Navigator Securities Lending Portfolio II     | CUSIP: 857492706<br>LEI: 5493008BJIBKQ5KTIF74 | Long             | STIV             | RF                | US        |  15318033 | NS      | $15318033.00  | 6.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Alumis Inc                       | Alumis Inc                                                 | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     75453 | NS      | $736421.28    | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Amneal Pharmaceuticals Inc       | Amneal Pharmaceuticals Inc                                 | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |    350889 | NS      | $4421201.40   | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc    | Amphastar Pharmaceuticals Inc                              | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |    140767 | NS      | $3769740.26   | 1.64%             |  |  |  | No            |                  1 | On Loan: —       |
| Amylyx Pharmaceuticals Inc       | Amylyx Pharmaceuticals Inc                                 | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    323836 | NS      | $3911938.88   | 1.70%             |  |  |  | No            |                  1 | On Loan: —       |
| Aquestive Therapeutics Inc       | Aquestive Therapeutics Inc                                 | CUSIP: 03843E104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    465934 | NS      | $3009933.64   | 1.31%             |  |  |  | No            |                  1 | On Loan: —       |
| Arvinas Inc                      | Arvinas Inc                                                | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    323442 | NS      | $3836022.12   | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc          | Axsome Therapeutics Inc                                    | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     28704 | NS      | $5242498.56   | 2.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co          | Bristol-Myers Squibb Co                                    | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     83663 | NS      | $4512782.22   | 1.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc     | Collegium Pharmaceutical Inc                               | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     87686 | NS      | $4059861.80   | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc         | Corcept Therapeutics Inc                                   | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     50221 | NS      | $1747690.80   | 0.76%             |  |  |  | No            |                  1 | On Loan: —       |
| CorMedix Inc                     | CorMedix Inc                                               | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |    325517 | NS      | $3785762.71   | 1.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Crinetics Pharmaceuticals Inc    | Crinetics Pharmaceuticals Inc                              | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |     89146 | NS      | $4149746.30   | 1.80%             |  |  |  | No            |                  1 | On Loan: —       |
| Edgewise Therapeutics Inc        | Edgewise Therapeutics Inc                                  | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    180470 | NS      | $4478363.05   | 1.95%             |  |  |  | No            |                  1 | On Loan: —       |
| Elanco Animal Health Inc         | Elanco Animal Health Inc                                   | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    201143 | NS      | $4551866.09   | 1.98%             |  |  |  | No            |                  1 | On Loan: —       |
| Enliven Therapeutics Inc         | Enliven Therapeutics Inc                                   | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    161593 | NS      | $2488532.20   | 1.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Esperion Therapeutics Inc        | Esperion Therapeutics Inc                                  | CUSIP: 29664W105<br>LEI: 549300OFU56UKEWVUS92 | Long             | EC               | CORP              | US        |   1118628 | NS      | $4138923.60   | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                       | Evolus Inc                                                 | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |    333163 | NS      | $2215533.95   | 0.96%             |  |  |  | No            |                  1 | On Loan: —       |
| EyePoint Inc                     | EyePoint Inc                                               | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |    256241 | NS      | $4681523.07   | 2.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Harmony Biosciences Holdings Inc | Harmony Biosciences Holdings Inc                           | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    109100 | NS      | $4082522.00   | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Harrow Inc                       | Harrow Inc                                                 | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     85345 | NS      | $4181905.00   | 1.82%             |  |  |  | No            |                  1 | On Loan: —       |
| Innoviva Inc                     | Innoviva Inc                                               | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |    207776 | NS      | $4153442.24   | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                | Johnson & Johnson                                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     20743 | NS      | $4292763.85   | 1.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Zevra Therapeutics Inc           | Zevra Therapeutics Inc                                     | CUSIP: 488445206<br>LEI: 254900CU6T74V18Y1W18 | Long             | EC               | CORP              | US        |    291732 | NS      | $2613918.72   | 1.14%             |  |  |  | No            |                  1 | On Loan: —       |
| LENZ Therapeutics Inc            | LENZ Therapeutics Inc                                      | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    138668 | NS      | $2218688.00   | 0.96%             |  |  |  | No            |                  1 | On Loan: —       |
| Ligand Pharmaceuticals Inc       | Ligand Pharmaceuticals Inc                                 | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     23281 | NS      | $4401738.67   | 1.91%             |  |  |  | No            |                  1 | On Loan: —       |
| Eli Lilly & Co                   | Eli Lilly & Co                                             | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      4312 | NS      | $4634020.16   | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp                    | Liquidia Corp                                              | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    131100 | NS      | $4521639.00   | 1.97%             |  |  |  | No            |                  1 | On Loan: —       |
| MBX Biosciences Inc              | MBX Biosciences Inc                                        | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    148659 | NS      | $4688704.86   | 2.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Maze Therapeutics Inc            | Maze Therapeutics Inc                                      | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     96097 | NS      | $3981298.71   | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                   | Merck & Co Inc                                             | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     43888 | NS      | $4619650.88   | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine MindMed Inc        | Mind Medicine MindMed Inc                                  | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | CA        |    346070 | NS      | $4633877.30   | 2.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Nektar Therapeutics              | Nektar Therapeutics                                        | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     74200 | NS      | $3137176.00   | 1.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Nuvation Bio Inc                 | Nuvation Bio Inc                                           | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    546473 | NS      | $4896398.08   | 2.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Ocular Therapeutix Inc           | Ocular Therapeutix Inc                                     | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |    278023 | NS      | $3375199.22   | 1.47%             |  |  |  | No            |                  1 | On Loan: —       |
| Omeros Corp                      | Omeros Corp                                                | CUSIP: 682143102<br>LEI: 549300CJWLXX2MXVVV71 | Long             | EC               | CORP              | US        |    224036 | NS      | $3847818.30   | 1.67%             |  |  |  | No            |                  1 | On Loan: —       |
| Organon & Co                     | Organon & Co                                               | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    596705 | NS      | $4278374.85   | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira BioSciences Inc           | Pacira BioSciences Inc                                     | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    170149 | NS      | $4403456.12   | 1.91%             |  |  |  | No            |                  1 | On Loan: —       |
| Pfizer Inc                       | Pfizer Inc                                                 | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    166188 | NS      | $4138081.20   | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Phathom Pharmaceuticals Inc      | Phathom Pharmaceuticals Inc                                | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    253875 | NS      | $4211786.25   | 1.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Phibro Animal Health Corp        | Phibro Animal Health Corp                                  | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |     99663 | NS      | $3723409.68   | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc | Prestige Consumer Healthcare Inc                           | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     69823 | NS      | $4307380.87   | 1.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapport Therapeutics Inc         | Rapport Therapeutics Inc                                   | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    142934 | NS      | $4336617.56   | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Septerna Inc                     | Septerna Inc                                               | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     77297 | NS      | $2155040.36   | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals Inc     | Supernus Pharmaceuticals Inc                               | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |     92815 | NS      | $4612905.50   | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc       | Tarsus Pharmaceuticals Inc                                 | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     52685 | NS      | $4313847.80   | 1.88%             |  |  |  | No            |                  1 | On Loan: —       |
| Terns Pharmaceuticals Inc        | Terns Pharmaceuticals Inc                                  | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |     96040 | NS      | $3880016.00   | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc           | Trevi Therapeutics Inc                                     | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    302354 | NS      | $3785472.08   | 1.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Ventyx Biosciences Inc           | Ventyx Biosciences Inc                                     | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    249901 | NS      | $2256606.03   | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| State Street Global Advisors     | State Street Institutional US Government Money Market Fund | CUSIP: 857492706<br>LEI: 549300BZ5TGIFZUZDZ37 | Long             | STIV             | RF                | US        |     83019 | NS      | $83019.25     | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                      | Viatris Inc                                                | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    369340 | NS      | $4598283.00   | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc     | Xeris Biopharma Holdings Inc                               | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    617340 | NS      | $4846119.00   | 2.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Zoetis Inc                       | Zoetis Inc                                                 | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |     36287 | NS      | $4565630.34   | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC       | Avadel Pharmaceuticals PLC                                 | CUSIP: 000000000<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |    199457 | NS      | $4298298.35   | 1.87%             |  |  |  | No            |                  1 | On Loan: —       |
| Indivior PLC                     | Indivior PLC                                               | CUSIP: 000000000<br>LEI: 213800V3NCQTY7IED471 | Long             | EC               | CORP              | GB        |    120856 | NS      | $4336313.28   | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC         | Jazz Pharmaceuticals PLC                                   | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     25971 | NS      | $4415070.00   | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC               | Royalty Pharma PLC                                         | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    111980 | NS      | $4326907.20   | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc         | Theravance Biopharma Inc                                   | CUSIP: 000000000<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |    104548 | NS      | $1956093.08   | 0.85%             |  |  |  | No            |                  1 | On Loan: —       |
| Perrigo Co PLC                   | Perrigo Co PLC                                             | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    316890 | NS      | $4411108.80   | 1.92%             |  |  |  | No            |                  1 | On Loan: —       |
| WaVe Life Sciences Ltd           | WaVe Life Sciences Ltd                                     | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |    211782 | NS      | $3600294.00   | 1.57%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2026-01-16

**Name of Applicant:** SPDR SERIES TRUST

**Signature:** Arthur Jensen

**Name of Signer:** Arthur Jensen

**Title:** Deputy Treasurer